ICYMI: Gitelman syndrome (GS) is common salt-wasting genetic tubulopathy causing hypokalaemia and hypomagnesemia. Chondrocalcinosis (CC) is a frequent feature of GS. Study of 57 GS pts - 79% had CC, esp in Cx spine, Knee & wrist. https://t.co/ctEAQq1zzL #RheumNow

• https://bit.ly/3AkeRez

In case you missed it… Breakthrough COVID infection. Breakthrough brilliance in a KOL A must read from Len Calabrese https://t.co/2Ljzau5nBG #RheumNow

• https://bit.ly/2XyIvPb

We've got a new podcast available for download! Dr Jack Cush reviews the news and journal reports and takes cases and questions from rheumatologists. https://t.co/ErJJ5XL8NA #RheumTwitter #RheumNow #medtwitter https://t.co/tqyVNyNYa4

• https://bit.ly/3hGuh5N

ICYMI: Population study shows risk of H. Zoster in adults to be high among bDMARD and CTX, also increased w/ AZA and HCQ but not MTX SSZ or LEF users. Data from 254065, 1,826311 Pt-Yrs F/U, 6295 new DMARD users, 17024 incident HZ https://t.co/1TeOAWN9LB #RheumNow

• https://bit.ly/3nB4v6B

ICYMI: Probenecid, an OAT3 inhibitor, has inhibitory effects on RNA viruses (influenza, RSV) & decreases ACE2 expression. May have utility in COVID-19 as it was shown to inhibit SARS-CoV-2 replication in animal models https://t.co/MClSjpqpSa #RheumNow

• https://go.nature.com/3AauBRg

Do More DMARDs Mean More Switching? Tune in to this week's podcast to find out. https://t.co/ErJJ5XL8NA #RheumNow #RheumTwitter #medtwitter https://t.co/5Ufk0XQbmb

• https://bit.ly/3hGuh5N

Looking for Rx updates? We’ve got them for you. https://t.co/FOfqUvZ8nx

• https://bit.ly/3EpKN3S

ACR Responds to 2022 Medicare Physician Fee Schedule Proposed Rule Read more: https://t.co/SVGhfhp6Fg #RheumNow #RheumTwitter #medtwitter https://t.co/g46wYCdary

• https://bit.ly/2XxjrrQ

Breakthrough COVID infection. Breakthrough brilliance in a KOL A must read from Len Calabrese https://t.co/2Ljzau5nBG

• https://bit.ly/2XyIvPb

A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor treatment with canakinumab (CAN), shows CAN to be effective and safe in a variety of PFS patients. https://t.co/4lqMhE6ikx #RheumNow #RheumTwitter #medtwitter https://t.co/yThiwJhcwO

• https://bit.ly/3hDprWE

32 RA pts; each w/ 2 stool samples >6 mos apart - stool metagenome sequencing stool samples and pt activity assessed. Microbiome most influenced by age, followed by those achieving minimum clinically important improvement https://t.co/unaEOOuP34

• https://bit.ly/2XnistZ

Gitelman syndrome (GS) is common salt-wasting genetic tubulopathy causing hypokalaemia and hypomagnesemia. Chondrocalcinosis (CC) is a frequent feature of GS. Study of 57 GS pts - 79% had CC, esp in Cx spine, Knee & wrist. https://t.co/ctEAQq1zzL

• https://bit.ly/3AkeRez

Another non stellar result for remdesivir Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): P3, randomised, controlled, open-label trial ⁦@TheLancetInfDis⁩ https://t.co/kNSNj9RM4K

• DEFINE_ME

#ACR21 abstracts now online! NOTE: To coincide with virtual meeting early access, information that goes beyond that contained in the abstract is under embargo until Nov. 1 at 10 AM ET. Browse → https://t.co/o0fpZCHZLC https://t.co/SaNrNQPgau

• Home - ACR Meeting Abstracts